首页 > 最新文献

Cleveland Clinic Journal of Medicine最新文献

英文 中文
How can I select the right thyroid hormone formulation for my patient with hypothyroidism? 如何为我的甲状腺功能减退症患者选择正确的甲状腺激素制剂?
IF 4.1 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-12-01 DOI: 10.3949/ccjm.92a.25042
Lea El Hage, Vinni Makin
{"title":"How can I select the right thyroid hormone formulation for my patient with hypothyroidism?","authors":"Lea El Hage, Vinni Makin","doi":"10.3949/ccjm.92a.25042","DOIUrl":"https://doi.org/10.3949/ccjm.92a.25042","url":null,"abstract":"","PeriodicalId":10245,"journal":{"name":"Cleveland Clinic Journal of Medicine","volume":"92 12","pages":"745-747"},"PeriodicalIF":4.1,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145653830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Barriers to cancer screening in transgender women. 跨性别女性癌症筛查的障碍。
IF 4.1 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-12-01 DOI: 10.3949/ccjm.92c.12001
Maryam Sattari
{"title":"Barriers to cancer screening in transgender women.","authors":"Maryam Sattari","doi":"10.3949/ccjm.92c.12001","DOIUrl":"https://doi.org/10.3949/ccjm.92c.12001","url":null,"abstract":"","PeriodicalId":10245,"journal":{"name":"Cleveland Clinic Journal of Medicine","volume":"92 12","pages":"721"},"PeriodicalIF":4.1,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145653832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Latent autoimmune diabetes in adults: Not type 1, not type 2, a little of both. 成人潜伏性自身免疫性糖尿病:不是1型,也不是2型,两者都有。
IF 4.1 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-12-01 DOI: 10.3949/ccjm.92a.25069
Michelle D Lundholm, Keren Zhou

Latent autoimmune diabetes in adults (LADA) is a slowly progressive form of autoimmune diabetes that shares features of type 1 and type 2 diabetes, often leading to misdiagnosis and a delay in starting needed insulin therapy. This review summarizes LADA's presentation, diagnostic criteria, and management, emphasizing the importance of testing for antibodies early in the course of disease when patients have atypical features of type 2 diabetes.

成人潜伏性自身免疫性糖尿病(LADA)是一种缓慢进展的自身免疫性糖尿病,具有1型和2型糖尿病的特征,经常导致误诊和延迟开始所需的胰岛素治疗。这篇综述总结了LADA的表现、诊断标准和治疗,强调了当患者具有2型糖尿病的非典型特征时,在病程早期进行抗体检测的重要性。
{"title":"Latent autoimmune diabetes in adults: Not type 1, not type 2, a little of both.","authors":"Michelle D Lundholm, Keren Zhou","doi":"10.3949/ccjm.92a.25069","DOIUrl":"https://doi.org/10.3949/ccjm.92a.25069","url":null,"abstract":"<p><p>Latent autoimmune diabetes in adults (LADA) is a slowly progressive form of autoimmune diabetes that shares features of type 1 and type 2 diabetes, often leading to misdiagnosis and a delay in starting needed insulin therapy. This review summarizes LADA's presentation, diagnostic criteria, and management, emphasizing the importance of testing for antibodies early in the course of disease when patients have atypical features of type 2 diabetes.</p>","PeriodicalId":10245,"journal":{"name":"Cleveland Clinic Journal of Medicine","volume":"92 12","pages":"757-763"},"PeriodicalIF":4.1,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145653815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
LADA: A case for starting insulin therapy at diagnosis. LADA:诊断时开始胰岛素治疗1例。
IF 4.1 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-12-01 DOI: 10.3949/ccjm.92a.25084
Byron J Hoogwerf
{"title":"LADA: A case for starting insulin therapy at diagnosis.","authors":"Byron J Hoogwerf","doi":"10.3949/ccjm.92a.25084","DOIUrl":"https://doi.org/10.3949/ccjm.92a.25084","url":null,"abstract":"","PeriodicalId":10245,"journal":{"name":"Cleveland Clinic Journal of Medicine","volume":"92 12","pages":"764-766"},"PeriodicalIF":4.1,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145653868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Failure to thrive in hospitalized older adults: More than a 'social admission'. 住院的老年人不能茁壮成长:不仅仅是“社会承认”。
IF 4.1 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-11-03 DOI: 10.3949/ccjm.92a.25033
Shoshana Streiter, Samir Tulebaev
{"title":"Failure to thrive in hospitalized older adults: More than a 'social admission'.","authors":"Shoshana Streiter, Samir Tulebaev","doi":"10.3949/ccjm.92a.25033","DOIUrl":"https://doi.org/10.3949/ccjm.92a.25033","url":null,"abstract":"","PeriodicalId":10245,"journal":{"name":"Cleveland Clinic Journal of Medicine","volume":"92 11","pages":"662-666"},"PeriodicalIF":4.1,"publicationDate":"2025-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145437612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Managing noninsulin glucose-lowering medications before surgery. 在手术前使用非胰岛素降糖药物。
IF 4.1 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-11-03 DOI: 10.3949/ccjm.92c.11001
Adam Kaplan
{"title":"Managing noninsulin glucose-lowering medications before surgery.","authors":"Adam Kaplan","doi":"10.3949/ccjm.92c.11001","DOIUrl":"https://doi.org/10.3949/ccjm.92c.11001","url":null,"abstract":"","PeriodicalId":10245,"journal":{"name":"Cleveland Clinic Journal of Medicine","volume":"92 11","pages":"651"},"PeriodicalIF":4.1,"publicationDate":"2025-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145437563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thyroid eye disease: What's the latest? 甲状腺眼病:最新进展如何?
IF 4.1 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-11-03 DOI: 10.3949/ccjm.92a.25043
Ashley B Vincent, Alexander R Engelmann, Catherine J Hwang, Christian Nasr

Thyroid eye disease (TED) is an inflammatory autoimmune condition now recognized as being associated not only with Graves hyperthyroidism but also with euthyroidism and hypothyroidism. A high index of suspicion is required to diagnose TED and to recognize sight-threatening disease. Care is best provided in a multidisciplinary setting among primary care clinicians, endocrinologists, and ophthalmologists. This review summarizes the pathophysiology, risk factors, clinical presentation, and activity and severity evaluation of TED as well as the most recent advances in its treatment.

甲状腺眼病(TED)是一种炎症性自身免疫性疾病,目前认为不仅与格雷夫斯甲状腺机能亢进有关,还与甲状腺功能亢进和甲状腺功能减退有关。诊断TED和识别威胁视力的疾病需要高度的怀疑。护理最好在多学科的环境中提供,包括初级保健临床医生、内分泌学家和眼科医生。本文综述了TED的病理生理学、危险因素、临床表现、活动和严重程度评估以及其治疗的最新进展。
{"title":"Thyroid eye disease: What's the latest?","authors":"Ashley B Vincent, Alexander R Engelmann, Catherine J Hwang, Christian Nasr","doi":"10.3949/ccjm.92a.25043","DOIUrl":"https://doi.org/10.3949/ccjm.92a.25043","url":null,"abstract":"<p><p>Thyroid eye disease (TED) is an inflammatory autoimmune condition now recognized as being associated not only with Graves hyperthyroidism but also with euthyroidism and hypothyroidism. A high index of suspicion is required to diagnose TED and to recognize sight-threatening disease. Care is best provided in a multidisciplinary setting among primary care clinicians, endocrinologists, and ophthalmologists. This review summarizes the pathophysiology, risk factors, clinical presentation, and activity and severity evaluation of TED as well as the most recent advances in its treatment.</p>","PeriodicalId":10245,"journal":{"name":"Cleveland Clinic Journal of Medicine","volume":"92 11","pages":"693-701"},"PeriodicalIF":4.1,"publicationDate":"2025-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145437709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Should we continue guideline-directed medical therapy in patients with heart failure with improved ejection fraction? 对于射血分数改善的心力衰竭患者,我们是否应该继续指导药物治疗?
IF 4.1 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-11-03 DOI: 10.3949/ccjm.92a.24111
Nicole Ann Tesoro, Sumanth Kumar Bandaru
{"title":"Should we continue guideline-directed medical therapy in patients with heart failure with improved ejection fraction?","authors":"Nicole Ann Tesoro, Sumanth Kumar Bandaru","doi":"10.3949/ccjm.92a.24111","DOIUrl":"https://doi.org/10.3949/ccjm.92a.24111","url":null,"abstract":"","PeriodicalId":10245,"journal":{"name":"Cleveland Clinic Journal of Medicine","volume":"92 11","pages":"667-670"},"PeriodicalIF":4.1,"publicationDate":"2025-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145437699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Teprotumumab for thyroid eye disease: A reality check. Teprotumumab治疗甲状腺眼病:现实检查
IF 4.1 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-11-03 DOI: 10.3949/ccjm.92a.25066
Julian Perry
{"title":"Teprotumumab for thyroid eye disease: A reality check.","authors":"Julian Perry","doi":"10.3949/ccjm.92a.25066","DOIUrl":"https://doi.org/10.3949/ccjm.92a.25066","url":null,"abstract":"","PeriodicalId":10245,"journal":{"name":"Cleveland Clinic Journal of Medicine","volume":"92 11","pages":"702-703"},"PeriodicalIF":4.1,"publicationDate":"2025-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145437756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lipoprotein 'little a': More than a little target in the management of cardiovascular risk? 脂蛋白“小a”:在心血管风险管理中不仅仅是一个小目标?
IF 4.1 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-11-03 DOI: 10.3949/ccjm.92b.11025
Brian F Mandell
{"title":"Lipoprotein 'little a': More than a <i>little</i> target in the management of cardiovascular risk?","authors":"Brian F Mandell","doi":"10.3949/ccjm.92b.11025","DOIUrl":"https://doi.org/10.3949/ccjm.92b.11025","url":null,"abstract":"","PeriodicalId":10245,"journal":{"name":"Cleveland Clinic Journal of Medicine","volume":"92 11","pages":"647-648"},"PeriodicalIF":4.1,"publicationDate":"2025-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145437633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cleveland Clinic Journal of Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1